
Meniere’s disease
People with Ménière’s disease suffer from sudden attacks of dizziness. The symptoms are debilitating and associated with reduced function and quality of life, and risk of falls. The project investigates interregional differences in diagnosis and treatment.


Dizziness is a common but subjective symptom. Studies indicate that 17-30% of people have experienced dizziness affecting daily activities. These symptoms are often debilitating, linked to reduced function and quality of life, increased risk of falls, morbidity, and mortality. Meniere’s disease, a particularly severe form, involves sudden vertigo episodes, tinnitus, fluctuating hearing, and a sense of fullness in the ear. Quality of life declines, as many patients struggle to maintain employment and avoid social interactions out of fear of new episodes.
Meniere’s disease also imposes substantial socio-economic costs due to sick leave, early retirement, and frequent healthcare consultations. While theories about potential treatments abound, there remains a need for further testing to advance diagnostic and therapeutic understanding. There is also a stark interregional disparity in diagnosis rates: Sweden has ten times as many diagnosed cases as Denmark, for reasons still unknown. Increased knowledge of the disease can thus illuminate both its nature and the inequalities surrounding it.
Therefore, improved knowledge and collaboration across the Øresund region are essential. The bridge-building project aims to foster more equal healthcare access and develop personalized treatments. The project’s goal is to expand understanding of Meniere’s disease through a research network in the program region, enabling a more evidence-based approach to diagnosis and treatment.



Projektpartnere
- Department of Ear, Nose, and Throat, Zealand University Hospital
- Department of Ear, Nose, and Throat, Skåne University Hospital, Lund
- The Research Unit, Zealand University Hospital